Healthcare Equipment and Supplies
Company Overview of ORTHOCON, Inc.
ORTHOCON, Inc. develops, manufactures, markets, and sells implantable products to stop bone bleeding. The company provides HEMASORB, a ready-to-use, biocompatible, water resistant, and absorbable putty designed to stop bleeding when applied to damaged or cut bone. It offers its products through distributors. ORTHOCON, Inc. was formerly known as Ortho Therapeutics, LLC and changed its name to ORTHOCON, Inc. in January 2005. The company was founded in 2003 and is based in Irvington, New York. As of April 24, 2013, ORTHOCON, Inc. operates as a subsidiary of Abyrx, Inc.
1 Bridge Street
Irvington, NY 10533
Founded in 2003
Key Executives for ORTHOCON, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ORTHOCON, Inc., please visit www.orthocon.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.